Yohimbine in Medical Use: Which Tests Are Needed
Yohimbine is an alkaloid from the bark of the African yohimbe tree. It has a long history in medicine, mainly for erectile dysfunction, and a more recent reputation in fitness circles as a fat-loss aid. Because it acts powerfully on the nervous system, careful assessment is needed whenever it is used medically. Our editorial team explains which tests and checks matter and why.
What yohimbine does
Yohimbine is an alpha-2 adrenergic receptor antagonist. Alpha-2 receptors normally act as a brake on the release of noradrenaline. By blocking them, yohimbine increases sympathetic nervous system activity, raising heart rate, blood pressure, alertness and, in some cases, anxiety.
This mechanism explains both its intended effects and its risks. Increased sympathetic activity can improve blood flow to the penis and mobilise fat from fat stores, but it can also provoke palpitations, tremor and panic attacks in susceptible people.
Historically, yohimbine hydrochloride was used to treat erectile dysfunction. A meta-analysis by Ernst and Pittler (1998) suggested it was superior to placebo, but modern drugs such as PDE5 inhibitors have largely replaced it. In the UK, yohimbine is a prescription-only medicine, and licensed products are not currently in routine use.
In sport, a small study in professional footballers (Ostojic, 2006) reported a reduction in body fat with yohimbine supplementation, but evidence remains limited. Yohimbine is not on the WADA prohibited list, but it is on WADA's monitoring programme, and contaminated or mislabelled products are a recognised risk.
Assessment before starting
Before any medical use of yohimbine, a doctor would normally review the patient's history and perform baseline checks. The aim is to identify conditions in which increased sympathetic activity could be harmful.
| Check | What it identifies | Why it matters |
|---|---|---|
| Blood pressure (clinic and home) | Hypertension | Yohimbine can raise blood pressure significantly |
| Resting heart rate and ECG | Arrhythmias, conduction problems | Risk of palpitations and rhythm disturbances |
| Mental health history | Anxiety, panic disorder, PTSD, bipolar disorder | Yohimbine can provoke panic and mania |
| Kidney function (eGFR, creatinine) | Renal impairment | Affects drug clearance and blood pressure control |
| Liver function tests | Hepatic impairment | Yohimbine is metabolised in the liver |
| Blood glucose or HbA1c | Diabetes | Sympathetic activation affects glucose |
| Medication review | Interacting drugs | Risk of hypertensive or serotonergic reactions |
Erectile dysfunction itself can be an early sign of cardiovascular disease. That is why UK guidance recommends a cardiovascular risk assessment, including blood pressure, lipids and glucose, in men presenting with this problem, regardless of which treatment is chosen.
A baseline lipid profile and, where relevant, testosterone level help identify underlying causes that might be more appropriately treated directly.
Cardiovascular monitoring
The heart and blood vessels are the main area of concern. Yohimbine has been associated with episodes of severe hypertension, tachycardia and, in case reports, more serious cardiovascular events, especially at high doses or in combination with other stimulants.
During treatment, patients are usually advised to measure their blood pressure at home, particularly in the first weeks. A sustained rise or symptoms such as chest pain, severe headache or palpitations should prompt urgent medical review.
In people with known heart disease, an ECG and specialist advice are essential before any use. Yohimbine is generally considered unsuitable for those with uncontrolled hypertension, angina, previous heart attack or significant arrhythmias.
A review of yohimbine toxicity (Cimolai and Cimolai, 2011) described cases involving agitation, hypertension and arrhythmias, often linked to supplement products of uncertain content.
Mental health and drug interactions
Yohimbine has been used in research specifically to provoke anxiety. Studies by Charney and colleagues (1984) showed that it triggered panic attacks in people with panic disorder far more often than in healthy volunteers. This makes careful psychiatric screening a key part of assessment.
People with anxiety disorders, PTSD, bipolar disorder or a history of psychosis are generally advised against yohimbine. Sleep problems may also worsen.
- MAO inhibitors: risk of dangerous hypertensive reactions.
- Tricyclic antidepressants: may increase blood pressure effects.
- Clonidine and other alpha-2 agonists: direct pharmacological opposition.
- Antihypertensive medicines: reduced effectiveness.
- Stimulants and caffeine: additive cardiovascular strain.
A complete medication review, including over-the-counter products and supplements, is therefore one of the most important "tests" before use.
Supplements and the quality problem
Many products sold as "yohimbe" or for fat loss contain unknown quantities of yohimbine. An analysis of US supplements (Cohen et al., 2016) found that many labels were inaccurate, with some products containing pharmaceutical-level doses and others almost none.
The European Food Safety Authority (2013) concluded that it could not establish the safe use of yohimbe in food supplements because of insufficient data. Following this, the EU restricted the use of yohimbe in foods, and similar caution applies in Great Britain.
For this reason, the tests described above are not just a formality. Even products marketed as natural can contain enough yohimbine to cause serious side effects in people with undiagnosed hypertension or anxiety.
Anyone experiencing chest pain, a pounding headache, confusion or severe anxiety after taking a yohimbine-containing product should seek medical help immediately via NHS 111 or emergency services.
Editorial conclusions
Yohimbine is an alpha-2 antagonist that increases sympathetic activity, with real risks for the heart and mental health.
Before medical use, key checks include blood pressure, heart rate and ECG, kidney and liver function, glucose, psychiatric history and a full medication review.
Product quality in supplements is unreliable, so medical assessment matters even more when the dose is uncertain.
Our editorial team also suggests reading about evidence-based fat-loss strategies, the cardiovascular effects of stimulants and how to check whether a supplement is batch-tested.
References
- Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998;159(2):433–436.
- Charney DS, Heninger GR, Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry. 1984;41(8):751–763.
- Cimolai N, Cimolai T. Yohimbine use for physical enhancement and its potential toxicity. J Diet Suppl. 2011;8(4):346–354.
- Cohen PA, Wang YH, Maller G, DeSouza R, Khan IA. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8(3–4):357–369.
- EFSA Panel on Food Additives and Nutrient Sources added to Food. Scientific opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum.) Pierre ex Beille). EFSA J. 2013;11(7):3302.
- Ostojic SM. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med. 2006;14(4):289–299.
